Committed to improving women’s health and quality of life
Arstat Pharmaceuticals
Advancing
Transformational Products for Tens of Millions of Women
One of the Strongest Portfolios in Women’s Health
10 Granted US Patents
NUVOCEPT
TM
The first and only
oral contraceptive formulated for overweight and obese women
(≈60% of 10 million US pill users)
PREMRING
TM
First-in-class
medicated vaginal ring for uterine fibroids and endometriosis
(>15 million US women)
ENHANTA
TM
First-in-class
single non-hormonal therapy for painful, heavy menstrual periods
(>25 million US women)
Mission
Develop Safe and Effective Solutions for Highly Prevalent, Undertreated Reproductive Conditions and Disorders